Increased Specialization and Centralization Trend in Pharmaceutical Industry

Published: 2001-10-12 07:00:00

Updated: 2001-10-12 07:00:00

Following the completion of Korea Green Cross Corp.'s corporation division restructuring last year, Chong Kun Dang Corp. separated its Raw Material Manufacturing segment this month and is scheduled to establish an independent corporation. To boost their competitiveness the country's pharmaceutica...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK